AbbVie Inc.
Methods of Treating Glioblastoma

Last updated:

Abstract:

The present disclosure provides a method for treating cancer in a patient harboring an EGFR-expressing tumor and/or tumor cell, such as glioblastoma, comprising the combination of (i) applying an AC electric field to a target area, wherein the target area comprises an EGFR-expressing tumor or cancer cell); and (ii) administering an effective amount of depatuxizumab mafodotin.

Status:
Application
Type:

Utility

Filling date:

19 Nov 2018

Issue date:

26 Nov 2020